A Study of Reducing the Symptom Burden Produced by Chemoradiation Treatment for Head and Neck Cancer.

Trial Profile

A Study of Reducing the Symptom Burden Produced by Chemoradiation Treatment for Head and Neck Cancer.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Armodafinil (Primary) ; Bupropion (Primary) ; Minocycline (Primary) ; Curcumin
  • Indications Anorexia; Deglutition disorders; Fatigue; Pain; Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2013 New source identified and integrated (M.D. Anderson Cancer Center: 2009-0517).
    • 21 Mar 2013 Planned End Date changed from 1 Jul 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.
    • 08 Mar 2013 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top